2022
DOI: 10.6004/jnccn.2021.7277
|View full text |Cite
|
Sign up to set email alerts
|

EPR22-107: Evaluation of Early Risk of Moderate-to-Severe Cytokine Release Syndrome (CRS) Induced by CAR T-cell Therapy Using Pooled Clinical Trial Data

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles